Importance of Multi-lineage Hematologic Involvement and Hypoalbuminemia at Diagnosis in Patients With “Risk-organ” Multi-system Langerhans Cell Histiocytosis-Reference-Cited by-同舟云学术

Importance of Multi-lineage Hematologic Involvement and Hypoalbuminemia at Diagnosis in Patients With “Risk-organ” Multi-system Langerhans Cell Histiocytosis

Published:2010-05 Issue:4 Volume:32 Page:e122-e125
ISSN:1077-4114
Container-title:Journal of Pediatric Hematology/Oncology
language:en
Short-container-title:

Author:

Braier Jorge Luis,Rosso Diego,Latella Antonio,Chantada Guillermo,Ozuna Blanca,Ripoli Mario,Scopinaro Marcelo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference22 articles.

1. Hematology/oncology Clinics of North America;Aricó,1998

2. Histiocytic Disorders of Children and Adults;Gadner,2005

3. Concepts in staging and clinical studies for treatment of Langerhans Cell Histiocytosis;Komp;Semin Oncol,1991

4. LCH I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans Cell Histiocytosis: the histiocyte society;Ladisch;Med Pediatr Oncol,1994

5. Improved outcome in multisystem Langerhans Cell Histiocytosis is associated with therapy intensification;Gadner;Blood,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Langerhans cell histiocytosis in a patient with perianal lesion. A case report;Archivos Argentinos de Pediatria;2024-06-01

2. Histiocitosis de células de Langerhans en un paciente con lesión perianal. Caso clínico;Archivos Argentinos de Pediatria;2024-06-01

3. Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis;Heliyon;2023-09

4. Treatment of children with refractory/relapse high risk Langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone;2023-05-17

5. Clinical outcomes and screening for organ involvement in pediatric Langerhans cell histiocytosis in Thailand: multicenter study on behalf of the Thai Pediatric Oncology Group;International Journal of Hematology;2022-01-31